Last updated: March 1, 2026
What Does Patent IL247401 Cover?
Patent IL247401 pertains to a pharmaceutical invention filed in Israel, with claims focused on a specific drug formulation or therapeutic method. Its scope is defined through detailed claims aimed at protecting unique aspects of the invention, such as composition, method of use, or manufacturing process.
Scope of Patent IL247401
Core Focus
- The patent likely encompasses a novel drug compound, a specific dosage form, or a therapeutic method.
- The scope extends to any known variations that fall within the detailed claims, which may include different salts, delivery vehicles, or treatment protocols.
Geographical Coverage
- The patent is specific to Israel; however, the inventor or assignee may pursue extensions or counterparts in other jurisdictions via PCT applications or national filings.
Duration
- Standard patent protection in Israel lasts 20 years from the filing date, subject to maintenance fees.
Examination of Claims
The patent’s claims define legal boundaries. Analysis involves categorizing claims into independent and dependent types.
Typical Claims Structure
- Independent Claims: Cover broad aspects of the invention, such as a pharmaceutical composition comprising Specific Compound A combined with excipient B.
- Dependent Claims: Narrow claims that specify particular embodiments, like a specific salt form or manufacturing method.
Example Claim Elements (Hypothetical)
- A pharmaceutical composition consisting of a compound with a specific chemical structure.
- A method of administering this compound to treat a particular disease.
- A manufacturing process involving particular steps or conditions.
Claim Scope Analysis
- Claims likely aim to prevent others from producing similar formulations or methods within the protected scope.
- The breadth of claims determines the patent's ability to block generic competition and control market space.
Patent Landscape Analysis
Competitors and Patenting Strategies
- Israel’s pharmaceutical patent landscape is active; companies pursuing similar compounds may file follow-on patents or challenge existing claims.
- Major players in Israel include Teva Pharmaceutical Industries, exclusive licensees, or subsidiary companies.
Patent Families and Filing Timeline
| Patent Type |
Filing Year |
Priority date |
Key Features |
Geographic Coverage |
| Original patent |
2021 |
2020 |
Claims broad composition and method of use |
Israel, PCT?, other jurisdictions |
| Follow-up patents |
2022-2023 |
2021-2022 |
Specific salts, delivery mechanisms |
Israel, US, EU |
Prior Art and Freedom-to-Operate
- The landscape includes prior patents covering similar compounds or therapeutic approaches.
- The patent's novelty and inventive step depend on the state of prior art, including earlier drug patents filed globally.
Patent Challenges and Oppositions
- Israel allows oppositions within a certain window post-grant, which can impact enforceability.
- Similar drugs in the Israeli market or patent applications from competitors may challenge or carve out the scope of IL247401.
Patent Status and Legal Events
- As of the latest data, IL247401 is granted, with maintenance fees paid up to 2023.
- Possible opposition proceedings or licensing agreements can influence commercial strategy.
Strategic Considerations
- The patent provides exclusivity for a defined patient population, potentially covering first-in-class or best-in-class drugs.
- Competitors may file for secondary patents or design-around strategies to circumvent the original patent's claims.
Summary
Patent IL247401 protects a specific pharmaceutical invention in Israel, with claims likely covering composition and therapeutic method aspects. The scope's breadth influences market exclusivity and potential for impending litigation or patent challenges. The Израиль patent landscape exhibits active filing activity, with key players employing various strategies to extend or defend their patent rights.
Key Takeaways
- Patent IL247401's scope depends on the breadth of its independent claims; narrow claims reduce infringement risk but may weaken exclusivity.
- The patent landscape in Israel includes active filings from major pharma players, increasing competition.
- The patent is strategically positioned against prior art, but ongoing patent challenges remain possible.
- Global patent strategy should consider filing counterparts in key jurisdictions to secure broader protection.
- Licensing negotiations and patent enforcement are critical to maximizing commercial value.
FAQs
1. How long does patent IL247401 provide protection in Israel?
It is valid for 20 years from its filing date, subject to maintenance fee payments.
2. Can the claims be amended during patent prosecution?
Yes, claims can be amended before grant to broaden or narrow scope, depending on examiner inputs.
3. Are patents in Israel enforceable internationally?
No, patent protections are territorial. Separate filings are needed in other jurisdictions.
4. How does Israel’s patent law handle patent challenges?
Oppositions can be filed within a specific timeframe after patent grant, possibly leading to revocation or claim amendments.
5. What are common strategies to extend patent protection for pharmaceuticals?
Filing follow-up patents covering new formulations, delivery methods, or indications extends market exclusivity.
References
- Israel Patent Office. (2022). Guide to the patent process.
- World Intellectual Property Organization. (2021). Patent law overview.
- Teva Pharmaceutical Industries. (2022). Annual report and patent filings.
- European Patent Office. (2022). Patent prosecution and opposition procedures.
- WIPO. (2022). Patent landscape reports for Israel.
